Skip to main content

Table 4 The total costs (USD) in the adjuvant treatment of premenopausal patients with stage Ia to IIIa breast cancer in Taiwan

From: Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer

 

Drug Costs

Surgery

G-CSF Treatment

Blood Testing

Chemo Costs

Total Costs

 

BSA 1.5 m2

BSA 1.8 m2

    

BSA 1.5 m2

BSA 1.8 m2

Goserelin

5,532

0

0

0

0

5,532

Chemotherapy

        

   CMF

149

156

438

651

59

492

1,789

1,795

   FEC

1,964

1,970

438

651

59

492

3,603

3,610

   TE

10,813

12,145

438

651

59

492

12,453

13,785

   TEC

10,878

12,210

438

651

59

492

12,517

13,849

  1. BSA, body surface area; CMF, (cyclophosphamide, methotrexate, 5-fluorouracil); FEC, (5-fluorouracil, epirubicin, cyclophosphamide); TE (docetaxel, epirubicin); TEC, (docetaxel, epirubicin, cyclophosphamide)
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us